All Discussions Tagged 'FDA' (50)

Discussions Replies Latest Activity

Victoza (liraglutide) for obesity: thoughts on weight management, diabetes, and quality of life

Victoza (liraglutide) is a once-daily injection that is currently approved for the treatment of type 2 diabetes. Right now, Victoza comes i…

Started by Manny Hernandez

15 1 hour ago
Reply by Brian (bsc)

530G with Enlite Experience?

I'm curious about the feedback from people who're using the Medtronic 530G with Enlite. I tried the 530G with Enlite for 24-hour and didn't…

Started by Allie Beatty

10 Aug 11
Reply by Allie Beatty

Consensus Conference on glucose monitoring, patient input needed!

On September 28th there will be a Consensus Conference in DC, in which representatives from (1) government, payers, employers; (2) advocacy…

Started by Emily Coles

15 Aug 5
Reply by shoshana27

Tell FDA your thoughts on the proposed Nutrition Fact Label (by Aug. 1)

A change to the Nutrition Label we are so familiar with and food serving sizes used in labels is currently being considered by the Food and…

Started by Emily Coles

32 Aug 4
Reply by jbowler

FDA Delays Decision on Inhaled Insulin

This article was originally posted at DiabetesHealth.com The Food and Drug Administration (FDA) has delayed until July 15th making a decisi…

Started by Diabetes News and Interest

0 May 24

FDA Says GenStrip May Report False Results

FDA Safety Communication: Shasta Technologies GenStrip Blood Glucose Test Strips May Report False Results Date Issued: April 29, 2014 Audie…

Started by Diabetes News and Interest

0 Apr 29

Extra Time, Use it Wisely - Meter Accuracy

More Time! FDA has extended the comment period for glucose system guidance to May 7.  If you have commented, Thank You!   If you have not,…

Started by BadShoe

11 Apr 25
Reply by BadShoe

FDA delays Afrezza decision

Although this news came out a few weeks ago, I missed it. On April 7, 2014, the FDA extended until July 15, 2014 its decision on whether to…

Started by Terry

0 Apr 21

View Recent FDA Live Chat with Brett Dunlap of StripSafely.com

On March 31, 2014 our member Brett Dunlap had a live chat with FDA's Courtney Lias Ph.D, Director of Chemistry and Toxicology Devices conce…

Started by Brian (bsc)

0 Apr 16

FDA Approves New Once a Week GLP-1 Treatment for T2

GSK receives US approval for once-weekly type 2 diabetes treatment, TanzeumTM (albiglutide) Issued: Tuesday 15 April 2014, London UK – LSE…

Started by Diabetes News and Interest

0 Apr 15

RSS

Advertisement



REsources

From the Diabetes Hands Foundation blog...

Diabetes Among Hispanics: We’re not all the same

US Hispanics are often portrayed in the press as a single, monolithic group. But anyone who has spent any time in San Francisco’s Mission District or the Bronx can tell you, we’re not all the same. Now we’re finding out Read on! →

Diabetes entre los hispanos: no somos todos iguales

Traducido por Mila Ferrer.    A menudo los Hispanos en Estados Unidos son retratados en la prensa como un solo grupo, monolítico. Pero cualquiera que haya pasado algún tiempo en el  Mission District de San Francisco o el Bronx se Read on! →

Diabetes Hands Foundation Team

DHF TEAM

Manny Hernandez
(Co-Founder, Editor, has LADA)

Emily Coles
(Head of Communities, has type 1)

Mila Ferrer
(EsTuDiabetes Community Manager, mother of a child with type 1)

Mike Lawson
(Head of Experience, has type 1)

Corinna Cornejo
(Development Manager, has type 2)

Desiree Johnson  (Administrative and Programs Assistant, has type 1)


DHF VOLUNTEERS


Lead Administrator

Bradford (has type 1)


Administrators

Lorraine (mother of type 1)
Marie B (has type 1)

Brian (bsc) (has type 2)

Gary (has type 2)

David (dns) (type 2)

 

LIKE us on Facebook

Spread the word

Loading…

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

© 2014   A community of people touched by diabetes, run by the Diabetes Hands Foundation.

Badges  |  Contact Us  |  Terms of Service